ALL-VASCOR

Poland
|
2023
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • Allopurinol

Amsterdam Cohort Studies

The Netherlands
|
2022-2022
  • Adults (18-64 years)
  • People at high risk of STIs
  • Men who have sex with men
  • Primary care
  • Monkeypox virus
  • Mpox
  • Pharmacological intervention
  • Vaccination

Mpox-Cohort

Italy
|
2022-2022
  • Adults (18-64 years)
  • Fragile population
  • PrEP users
  • People living with HIV
  • Hospital
  • Outpatient clinic
  • Infectious diseases unit
  • Monkeypox virus
  • Mpox
  • Pharmacological intervention
  • Vaccination
  • MVA-BN

Zuiani

United Kingdom United States of America
|
2023-2026
  • Adults (18-64 years)
  • General population
  • Monkeypox virus
  • Mpox
  • Pharmacological intervention
  • Vaccination
  • BNT166a

BLOC

Austria Finland Germany Spain Switzerland
|
2023-2024
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • BC 007